Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Predictors of the chest CT score in COVID-19 patients: a cross-sectional studyVirology journal, 2021-11, Vol.18 (1), p.225-225, Article 225 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1743-422X ;EISSN: 1743-422X ;DOI: 10.1186/s12985-021-01699-6 ;PMID: 34794467Full text available |
|
2 |
Material Type: Article
|
Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort StudyActa medica Iranica, 2017-04, Vol.55 (4), p.233-240 [Peer Reviewed Journal]Copyright Tehran University of Medical Sciences 2017 ;ISSN: 0044-6025 ;EISSN: 1735-9694 ;PMID: 28532134Full text available |
|
3 |
Material Type: Article
|
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19Antimicrobial agents and chemotherapy, 2020-08, Vol.64 (9) [Peer Reviewed Journal]Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01061-20 ;PMID: 32661006Full text available |
|
4 |
Material Type: Article
|
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trialPharmacological reports, 2022-02, Vol.74 (1), p.229-240 [Peer Reviewed Journal]The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences 2021 ;2021. The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences. ;ISSN: 1734-1140 ;EISSN: 2299-5684 ;DOI: 10.1007/s43440-021-00341-0 ;PMID: 34837648Full text available |
|
5 |
Material Type: Article
|
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavirDaru, 2020-12, Vol.28 (2), p.625-634 [Peer Reviewed Journal]Springer Nature Switzerland AG 2020 ;COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;ISSN: 2008-2231 ;ISSN: 1560-8115 ;EISSN: 2008-2231 ;DOI: 10.1007/s40199-020-00369-2 ;PMID: 32857301Full text available |